EVpedia 2.0

This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:

Superdomain: All Prokaryote Eukaryote

Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).

Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.

Number of molecules in one page:

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name	miRBase accession	FPR	TPR	Publication	Orthologous group	Identification count All / Prokaryote / Eukaryote (FPR<0.05,TPR<0.5)
hsa-miR-378a-3p	MIMAT0000732	0.0e+0	3.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000168_2	24 / 0 / 24
hsa-miR-378a-3p	MIMAT0000732	0.0e+0	3.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000168_2	24 / 0 / 24
hsa-miR-378i	MIMAT0019074	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8
hsa-miR-378i	MIMAT0019074	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8
hsa-miR-3934-5p	MIMAT0018349	0.0e+0	2.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001584_1	12 / 0 / 12
hsa-miR-3934-5p	MIMAT0018349	0.0e+0	1.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001584_1	12 / 0 / 12
hsa-miR-3937	MIMAT0018352	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001500_1	23 / 0 / 23
hsa-miR-3937	MIMAT0018352	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001500_1	23 / 0 / 23
hsa-miR-3940-5p	MIMAT0019229	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001599_1	21 / 0 / 21
hsa-miR-3945	MIMAT0018361	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	9 / 0 / 9
hsa-miR-3960	MIMAT0019337	0.0e+0	9.1e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001271_1	42 / 0 / 42
hsa-miR-3960	MIMAT0019337	0.0e+0	8.8e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001271_1	42 / 0 / 42
hsa-miR-3976	MIMAT0019361	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-3976	MIMAT0019361	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-423-5p	MIMAT0004748	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000329_1	40 / 0 / 40
hsa-miR-423-5p	MIMAT0004748	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000329_1	40 / 0 / 40
hsa-miR-424-5p	MIMAT0001341	0.0e+0	4.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000164_1	26 / 0 / 26
hsa-miR-4253	MIMAT0016882	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	19 / 0 / 19
hsa-miR-4253	MIMAT0016882	0.0e+0	4.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	19 / 0 / 19
hsa-miR-4257	MIMAT0016878	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4257	MIMAT0016878	0.0e+0	3.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4259	MIMAT0016880	0.0e+0	2.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	13 / 0 / 13
hsa-miR-4259	MIMAT0016880	0.0e+0	2.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	13 / 0 / 13
hsa-miR-4261	MIMAT0016890	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4270	MIMAT0016900	0.0e+0	3.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	39 / 0 / 39
hsa-miR-4270	MIMAT0016900	0.0e+0	3.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	39 / 0 / 39
hsa-miR-4271	MIMAT0016901	0.0e+0	3.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	27 / 0 / 27
hsa-miR-4271	MIMAT0016901	0.0e+0	2.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	27 / 0 / 27
hsa-miR-4281	MIMAT0016907	0.0e+0	1.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	39 / 0 / 39
hsa-miR-4281	MIMAT0016907	0.0e+0	1.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	39 / 0 / 39
hsa-miR-4284	MIMAT0016915	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	12 / 0 / 12
hsa-miR-4284	MIMAT0016915	0.0e+0	1.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	12 / 0 / 12
hsa-miR-4286	MIMAT0016916	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	24 / 0 / 24
hsa-miR-4286	MIMAT0016916	0.0e+0	1.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	24 / 0 / 24
hsa-miR-4298	MIMAT0016852	0.0e+0	3.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	34 / 0 / 34
hsa-miR-4298	MIMAT0016852	0.0e+0	2.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	34 / 0 / 34
hsa-miR-4306	MIMAT0016858	0.0e+0	2.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4306	MIMAT0016858	0.0e+0	2.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4317	MIMAT0016872	0.0e+0	4.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	2 / 0 / 2
hsa-miR-4327	MIMAT0016889	0.0e+0	3.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4327	MIMAT0016889	0.0e+0	3.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4430	MIMAT0018945	0.0e+0	5.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	19 / 0 / 19
hsa-miR-4430	MIMAT0018945	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	19 / 0 / 19
hsa-miR-4433a-3p	MIMAT0018949	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001826_2	14 / 0 / 14
hsa-miR-4433a-3p	MIMAT0018949	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001826_2	14 / 0 / 14
hsa-miR-4442	MIMAT0018960	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	27 / 0 / 27
hsa-miR-4442	MIMAT0018960	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	27 / 0 / 27
hsa-miR-4443	MIMAT0018961	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-4443	MIMAT0018961	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-4454	MIMAT0018976	0.0e+0	1.7e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	31 / 0 / 31
hsa-miR-4454	MIMAT0018976	0.0e+0	6.9e-3	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	31 / 0 / 31
hsa-miR-4459	MIMAT0018981	0.0e+0	5.8e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	33 / 0 / 33
hsa-miR-4459	MIMAT0018981	0.0e+0	4.4e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	33 / 0 / 33
hsa-miR-4463	MIMAT0018987	0.0e+0	4.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	30 / 0 / 30
hsa-miR-4463	MIMAT0018987	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	30 / 0 / 30
hsa-miR-4466	MIMAT0018993	0.0e+0	2.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	33 / 0 / 33
hsa-miR-4466	MIMAT0018993	0.0e+0	2.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	33 / 0 / 33
hsa-miR-4468	MIMAT0018995	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	9 / 0 / 9
hsa-miR-4484	MIMAT0019018	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001440_1	29 / 0 / 29
hsa-miR-4484	MIMAT0019018	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001440_1	29 / 0 / 29
hsa-miR-4485-3p	MIMAT0019019	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-4485-3p	MIMAT0019019	0.0e+0	2.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-4486	MIMAT0019020	0.0e+0	4.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4499	MIMAT0019035	0.0e+0	4.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	16 / 0 / 16
hsa-miR-4499	MIMAT0019035	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	16 / 0 / 16
hsa-miR-4505	MIMAT0019041	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	31 / 0 / 31
hsa-miR-4505	MIMAT0019041	0.0e+0	2.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	31 / 0 / 31
hsa-miR-4507	MIMAT0019044	0.0e+0	4.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	29 / 0 / 29
hsa-miR-4507	MIMAT0019044	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	29 / 0 / 29
hsa-miR-4516	MIMAT0019053	0.0e+0	1.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	36 / 0 / 36
hsa-miR-4516	MIMAT0019053	0.0e+0	1.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	36 / 0 / 36
hsa-miR-4516	MIMAT0019053	0.0e+0	9.3e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	36 / 0 / 36
hsa-miR-451a	MIMAT0001631	0.0e+0	1.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000148_1	104 / 0 / 104
hsa-miR-451a	MIMAT0001631	0.0e+0	9.2e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000148_1	104 / 0 / 104
hsa-miR-4530	MIMAT0019069	0.0e+0	1.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	33 / 0 / 33
hsa-miR-4530	MIMAT0019069	0.0e+0	1.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	33 / 0 / 33
hsa-miR-4532	MIMAT0019071	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4534	MIMAT0019073	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	25 / 0 / 25
hsa-miR-4534	MIMAT0019073	0.0e+0	3.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	25 / 0 / 25
hsa-miR-4632-5p	MIMAT0022977	0.0e+0	4.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-4634	MIMAT0019691	0.0e+0	4.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4634	MIMAT0019691	0.0e+0	3.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4644	MIMAT0019704	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	18 / 0 / 18
hsa-miR-4655-5p	MIMAT0019721	0.0e+0	3.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4655-5p	MIMAT0019721	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4669	MIMAT0019749	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4669	MIMAT0019749	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4685-5p	MIMAT0019771	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8
hsa-miR-4685-5p	MIMAT0019771	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8
hsa-miR-4687-3p	MIMAT0019775	0.0e+0	2.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	19 / 0 / 19
hsa-miR-4687-3p	MIMAT0019775	0.0e+0	2.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	19 / 0 / 19
hsa-miR-4689	MIMAT0019778	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	21 / 0 / 21
hsa-miR-4689	MIMAT0019778	0.0e+0	4.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	21 / 0 / 21
hsa-miR-4689	MIMAT0019778	0.0e+0	4.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	21 / 0 / 21
hsa-miR-4728-5p	MIMAT0019849	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	10 / 0 / 10
hsa-miR-4732-5p	MIMAT0019855	0.0e+0	1.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	12 / 0 / 12
hsa-miR-4732-5p	MIMAT0019855	0.0e+0	1.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	12 / 0 / 12
hsa-miR-4739	MIMAT0019868	0.0e+0	4.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	29 / 0 / 29
hsa-miR-4741	MIMAT0019871	0.0e+0	3.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	26 / 0 / 26
hsa-miR-4741	MIMAT0019871	0.0e+0	3.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	26 / 0 / 26

< [571] [572] [573] [574] [575] [576] [577] [578] [579] [580] >